Toxin B (TcdB) is a major pathogenic factor of Clostridum difficile. However, the mechanism by which TcdB exerts its cytotoxic action in host cells is still not completely known. Herein, we report for the first time that TcdB induced autophagic cell death in cultured human colonocytes. The induction of autophagy was demonstrated by the increased levels of LC3-II, formation of LC3 + autophagosomes, accumulation of acidic vesicular organelles and reduced levels of the autophagic substrate p62/SQSTM1.
| INTRODUCTION
Clostridium difficile is an anaerobic, Gram-positive, sporulating bacterium that gives rise to a spectrum of gastrointestinal diseases, including antibiotic-associated diarrhoea, pseudomembranous colitis and toxic megacolon. 1 C. difficile infection is a major cause of hospital-associated infection, accounting for about 3 million cases per year worldwide. 2 It is also the most common infectious cause of diarrhoea in Intensive Care Unit in which the prevalence is estimated to be about 4%. One-fifth of these ICU patients infected with C. difficile develop fulminant colitis with a mortality rate of nearly 60%. 3 The incidence of C. difficile is rapidly increasing, especially in developed countries. Therefore, C. difficile infection, which carries significant mortality and morbidity, remains a major health To this end, TcdB is 10 times more potent than TcdA in mediating the pathogenicity. 5 Cessation of the inciting antibiotic and treatment with metronidazole and vancomycin are the mainstay in the management of C. difficile infection. Nevertheless, high rates of non-responsiveness (~22%) and relapse (~27%) have been associated with metronidazole. In addition, the emergence of vancomycin-resistant enterococci is a major concern for vancomycin. 3 Several non-antibiotic treatment modalities, such as toxin neutralization, probiotics and faecal microbiota transplantation, have been attempted, but their efficacies remain to be established. Development of other non-antibiotic therapeutics for C. difficile infection is an area of active investigation.
Autophagy is a regulated intracellular degradation system, participating in various human diseases and physiological processes, such as cancer, neurodegeneration, microbial infection, ageing and heart disease. 6, 7 Although autophagy could be a cellular protective mechanism especially in times of nutrient deprivation and other stressful conditions, its extensive activation could mediate cell death. The precise role of autophagy in C. difficile-induced intestinal cell death and inflammation, however, remains unclear. In this study, we sought to investigate whether autophagy takes part in the cytotoxicity of TcdB in colonocytes. 
| RNA interference
Cells were seeded at a density of 8000 cells per well in 96-well plates prior to the transfection. During the transfection, the cells were transfected with small interfering RNA (Thermo Fisher) against autophagy-related genes (ie Beclin 1, Atg5 and Atg7) using the jet-PRIME transfection reagent (Polyplus) according to the manufacturer's instructions. 
| Statistical analysis
Statistical analysis was performed with one-way analysis of variance (ANOVA) followed by the Tukey's post hoc test. P values <.05 will be considered statistically significant.
3 | RESULTS
| TcdB reduces viability of colonocytes without inducing apoptosis
Colon is the primary anatomic site of C. difficile infection. We therefore determined the effect of TcdB on the viability of cultured human colonocytes. NCM460 cells were exposed to increasing concentrations of TcdB from 0.1 to 100 ng/mL for 24 or 48 hours followed by the CCK-8 assay. As shown in Figure 1A , A, Time-course and dose-dependent effect of TcdB-induced cell death in NCM460. NCM460 cells were cultured with the indicated concentrations (0.1-100 ng/mL) of TcdB for 24 or 48 h. Cell viability was assessed by CCK-8 assay. Results are expressed as percentage of control at corresponding time-points and represent the means AE SEM of 3 independent experiments. *P < .05; **P < .01; ****P < .0001 significantly different between groups. B, Doseresponse curve assessing cell viability in NCM460 cells after TcdB exposure. NCM460 cells were cultured with the indicated concentrations (0.1-1000 ng/mL) for 48 h. Cell viability was assessed by CCK-8 assay ( Figure 2B ), suggesting that apoptosis was not the primary cell death mechanism in TcdB-exposed colonocytes.
| TcdB induces autophagy in colonocytes
To further investigate the cell death mechanism underlying the cytotoxicity of TcdB in NCM460 cells, autophagy was assayed. First, the level of LC3B-II as a biomarker of autophagosome formation was determined in TcdB-exposed cells. As shown in Figure 3A , the induction of LC3B-II level by low-concentration TcdB (10 ng/mL) peaked at 6 hours and lessened afterwards. These results indicated that TcdB at low concentration could readily induce autophagy in NCM460 cells. Similarly, at the 6-hour time-point, higher concentrations of TcdB up to 300 ng/mL increased the levels of LC3B-II (Figure 3B) , during which autophagic flux was found to be increased as indicated by the reduced level of p62/SQSTM1 (an autophagic substrate). Importantly, TcdB-mediated p62/SQSTM1 down-regulation was not dependent of p62 gene transcription ( Figure 3C ). However, it is also noteworthy that the autophagic flux might be impaired Aside from the formation of LC3 + autophagosomes, increased staining of acidic vesicular organelles, including late endosomes, autolysosomes and lysosomes, is another important hallmark of autophagy. In this study, acridine orange, which emits bright red fluorescence in acidic intracellular compartments, was used to visualize putative acidic vesicular organelles. Colorimetric analysis demonstrated that TcdB (10 ng/mL) exposure resulted in a significant F I G U R E 2 Apoptosis is not the primary cell death mechanism of TcdB-exposed colonocytes. A, NCM460 cells were cultured with the indicated concentrations (0.1-100 ng/mL) of TcdB for 24 or 48 h. DNA fragmentation of apoptotic cells was assessed by TUNEL assay. Quantitative data represent means AE SEM of 3 independent experiments. **P < .01; ***P < .001; ****P < .0001 significantly different between groups. B, Exposure to TcdB (10 ng/mL) did not induce PARP cleavage in NCM460 cells.
), a known apoptosis inducer, was used as the positive control. Representative blots of 3 independent experiments are shown increase in red-to-green ratio in acridine orange-stained cells ( Figure 4B ) at 6 hours, indicating the acumination of acidic vesicular organelles.
| PTEN/PI3K/AKT/mTOR pathway is involved in TcdB-induced autophagy
The mechanistic target of rapamycin (mTOR) complex 1 is a wellknown negative regulator of autophagosome formation. The activity of mTOR complex 1 could be assessed by the phosphorylation levels of mTOR itself and its downstream substrates, such as p70-S6 kinase (p70-S6K). To determine whether TcdB-induced autophagy was associated with mTOR complex 1 repression, the phosphorylation levels of these 2 proteins were measured in NCM460 cells with or without exposure to TcdB. As shown in Figure 5A 
| Toxin glucosyltransferase activity is required for the pro-autophagic effect of TcdB
TcdB is known to exert its cytotoxic action through its glucosyltransferase activity, 9 which subsequently leads to cell rounding and cell death. To examine the critical role of glucosyltransferase activity in TcdB-induced autophagy, a non-competitive glucosyltransferase inhibitor phloretin 10 was used. As shown in Figure 5D , phloretin inhibited the TcdB-mediated induction of LC3B-II level. Atg5 encodes an E3 ubiquitin ligase necessary for autophagy due to its role in autophagosome elongation. As compared with the wild-type MEFs, the loss of cell viability induced by TcdB (10 and 100 ng/mL at the 48-hour time-point) was mitigated by Atg5 knockout ( Figure 6C ), confirming the pro-death nature of TcdBinduced autophagy.
F I G U R E 4
Enhanced formation of acidic vesicular organelles and autophagic flux in TcdB-exposed colonocytes. A, NCM460 cells were transfected with mCherry-GFP-labelled LC3 plasmid for 24 h followed by exposure to TcdB (10 ng/mL) or rapamycin (1.1 lmol L
À1
). Acidified and non-acidified LC3-positive autophagosomes were visualized and counted under a confocal microscope. Quantitative data represent means AE SEM of 3 independent experiments. **P < .01; ***P < .001; ****P < .0001 significantly different between groups. B, Acridine orange staining was performed to visualize TcdB-induced formation of acidic vesicular organelles (orange colour) in NCM460 under fluorescence microscopy. Quantitation of the red-to-green ratio represents means AE SEM of 3 independent experiments. *P < .05 significantly different between groups Another opinion, based on results from a hamster model, is that TcdB is vital for C. difficile virulence while TcdA was avirulent. 12 As the problems of unclear infection mechanism and emerging antibiotic resistance are serious, C. difficile infection has become more difficult to treat. Investigating the pathogenic mechanism would therefore help to devise new therapeutic approaches.
Previous studies have shown that TcdB is a potent cytotoxin capable of inducing enzyme-independent necrosis in both cells and tissue. 13 In this study, we focus on the role of autophagy. As autophagy is a complicated and dynamics process, various methods are required for more accurate analysis in monitoring autophagy. Cell viability was assessed by CCK-8 assay. C, Wild-type and Atg5 knockout mouse embryonic fibroblasts (MEFs) were exposed to TcdB at the indicated concentrations for 48 h. Cell viability was assessed by CCK-8 assay. Results are expressed as means of percentage of control AE SEM of 3 independent experiments. *P < .05; **P < .01; ***P < .001; ****P < .0001 significantly different between groups of nutrient deprivation and other stressful conditions, which could protect host cells against various forms of cellular insults, extensive activation of autophagy could mediate cell death.
mTOR complex 1 signalling pathway serves as a major player in transmitting the autophagic signals. In Saccharomyces cerevisiae, inhibition of TOR is required to control the Atg1-dependent organization of pre-autophagosomal elements and the expansion of the pre-autophagosomal membrane. 14, 15 In humans, inhibition of mTORC1 has been reported to induce autophagy in different biological context. For instances, mTOR inhibitors induce autophagy in lung cancer, glioma, mantle cell lymphoma and disseminated gastric cancer cells. [16] [17] [18] [19] In this study, we demonstrated that TcdB suppressed mTORC1 activity as demonstrated by reduced phosphorylation of mTOR and its substrate p70-S6K. We further demonstrated that TcdB suppressed mTOR com- Cdc42. Nevertheless, in this study, the glucosyltransferase activity of TcdB was found to be required for its pro-autophagic effect.
The current findings implicate that the use of autophagy inhibitor might attenuate the virulence of TcdB. Further animal studies would be required to assess the in vivo therapeutic effect of autophagy inhibition during C. difficile infection.
